Keyphrases
Immune Checkpoint Inhibitors
100%
Melanoma
100%
Tumor Metabolism
100%
Targeted Tumor
100%
Immune Cells
40%
Cancer Cells
40%
Tumor Growth
40%
Metabolic Pathway
40%
Tumor Microenvironment
40%
Tumor
20%
Clinical Application
20%
Metabolic
20%
Long-term Survival
20%
Immune Response
20%
Tumor Cells
20%
Microenvironment
20%
Melanoma Cells
20%
Patient Survival
20%
Antitumor Immune Response
20%
Metabolic Therapy
20%
Advanced Melanoma
20%
Tumor Cell Proliferation
20%
Melanoma Patients
20%
Immune Evasion
20%
Inhibit Tumor
20%
Non-cancer
20%
Immune Interactions
20%
Metabolic Reprogramming
20%
Cancer Hallmarks
20%
Immune Effect
20%
Tumor-immune System
20%
Treatment Landscape
20%
Pro-tumor
20%
Anti-tumor Immune
20%
Immunology and Microbiology
Immune Response
100%
Tumor Cell
100%
Metabolism
100%
Immunocompetent Cell
100%
Cancer Cell
50%
Long Term Survival
50%
Cell Growth
50%
Preclinical Study
50%
Immune Evasion
50%
Medicine and Dentistry
Nodular Melanoma
100%
Tumor Metabolism
100%
Neoplasm
60%
Tumor Progression
60%
Immune Response
40%
Immunocompetent Cell
40%
Metabolism
40%
Tumor Microenvironment
40%
Long Term Survival
20%
Tumor Cell
20%
Cancer Cell
20%
Immune Evasion
20%